Eagle Pharmaceuticals (NASDAQ:EGRX) Earns Hold Rating from Analysts at StockNews.com
Equities researchers at StockNews.com assumed coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a report issued on Sunday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Up 32.2 % EGRX opened at $1.19 on Friday. Eagle Pharmaceuticals has a 12-month low of $0.00 and […]
Equities researchers at StockNews.com assumed coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a report issued on Sunday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Stock Up 32.2 % EGRX opened at $1.19 on Friday. Eagle Pharmaceuticals has a 12-month low of $0.00 and […]
